AlphaYouSK
Insider selling
Sanj K Patel sold $26.4M of Kiniksa Pharmaceuticals International, plc (KNSA) stock
Sanj K Patel, Chairman & CEO of Kiniksa Pharmaceuticals International, plc (KNSA), sold 508,339 shares of KNSA stock worth $26.4M, per an SEC Form 4 filed Apr 30, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Apr 28, 2026, 2 days before it was made public.
KNSA has moved +45.1% since the trade date, from $53.85 to $78.13 (Sep 21, 2026 close).
- Traded
- Apr 28, 2026
- Disclosed
- Apr 30, 2026
- Filing delay
- 2 days
- Price since
- +45.1%
- Role
- Chairman & CEO
- Source
- SEC Form 4
More KNSA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.